Literature DB >> 7690825

Granulocyte colony-stimulating factor protects control rats but not ethanol-fed rats from fatal pneumococcal pneumonia.

P D Lister1, M J Gentry, L C Preheim.   

Abstract

A model of chronic ethanol ingestion was used to study the effects of granulocyte colony-stimulating factor (G-CSF) on the pathogenesis of pneumococcal pneumonia in intoxicated rats. G-CSF or 5% dextrose in water (D5W) was administered subcutaneously to ethanol-fed and pair-fed control rats on days 6 and 7 of pair feeding. Rats were infected transtracheally with type 3 Streptococcus pneumoniae on day 8. In pair-fed control rats, G-CSF significantly increased the total number and percentage of polymorphonuclear leukocytes (PMNL) in the peripheral blood (P < .001), augmented PMNL recruitment to infected lungs (P < .01), and significantly increased survival from pneumococcal pneumonia (P = .01). In contrast, treatment of ethanol-fed rats with G-CSF did not enhance pulmonary PMNL delivery and did not increase survival following experimental pneumococcal pneumonia, despite a significant increase in the total number and percentage of circulating PMNL (P < .001). These data suggest that despite increasing the numbers of circulating PMNL, G-CSF is unable to provide protection against fatal pneumococcal pneumonia in ethanol-fed rats.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7690825     DOI: 10.1093/infdis/168.4.922

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

Review 1.  Nursing home-acquired pneumonia. Treatment options.

Authors:  T J Marrie; K L Slayter
Journal:  Drugs Aging       Date:  1996-05       Impact factor: 3.923

2.  The pneumococcus: host-organism interactions and their implications for immunotherapy and immunoprophylaxis.

Authors:  F E Perry; J R Catterall
Journal:  Thorax       Date:  1994-10       Impact factor: 9.139

Review 3.  Alcohol abuse and Streptococcus pneumoniae infections: consideration of virulence factors and impaired immune responses.

Authors:  Minny Bhatty; Stephen B Pruett; Edwin Swiatlo; Bindu Nanduri
Journal:  Alcohol       Date:  2011-09       Impact factor: 2.405

Review 4.  Role of cytokines in pulmonary antimicrobial host defense.

Authors:  B Mehrad; T J Standiford
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

5.  Effects of granulocyte colony-stimulating factor on bacterial translocation due to burn wound sepsis.

Authors:  O Yalçin; G Soybir; F Köksoy; H Köse; R Oztürk; B Cokneşeli
Journal:  Surg Today       Date:  1997       Impact factor: 2.540

6.  Perioperative recombinant human granulocyte colony-stimulating factor (Filgrastim) treatment prevents immunoinflammatory dysfunction associated with major surgery.

Authors:  Christian Schneider; Sonja von Aulock; Siegfried Zedler; Christian Schinkel; Thomas Hartung; Eugen Faist
Journal:  Ann Surg       Date:  2004-01       Impact factor: 12.969

7.  Antifungal combination therapy with granulocyte colony-stimulating factor and fluconazole in experimental disseminated candidiasis.

Authors:  J R Graybill; R Bocanegra; M Luther
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-08       Impact factor: 3.267

8.  Neutrophil emigration in the skin, lungs, and peritoneum: different requirements for CD11/CD18 revealed by CD18-deficient mice.

Authors:  J P Mizgerd; H Kubo; G J Kutkoski; S D Bhagwan; K Scharffetter-Kochanek; A L Beaudet; C M Doerschuk
Journal:  J Exp Med       Date:  1997-10-20       Impact factor: 14.307

9.  Alcohol enhances Acinetobacter baumannii-associated pneumonia and systemic dissemination by impairing neutrophil antimicrobial activity in a murine model of infection.

Authors:  Jay A Gandhi; Vaibhav V Ekhar; Melissa B Asplund; Asan F Abdulkareem; Mohammed Ahmadi; Carolina Coelho; Luis R Martinez
Journal:  PLoS One       Date:  2014-04-21       Impact factor: 3.240

10.  The Effects of Granulocyte Colony-Stimulating Factor (G-CSF) in Pre-Clinical Models of Infection and Acute Inflammation.

Authors:  John C Marshall
Journal:  Sepsis (Boston)       Date:  1998
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.